PICHINI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 2.414
EU - Europa 1.119
AS - Asia 733
SA - Sud America 79
AF - Africa 57
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.408
Nazione #
US - Stati Uniti d'America 2.390
SG - Singapore 357
IT - Italia 260
RU - Federazione Russa 200
HK - Hong Kong 194
IE - Irlanda 154
SE - Svezia 122
CN - Cina 118
UA - Ucraina 102
DE - Germania 81
BR - Brasile 71
FR - Francia 51
CI - Costa d'Avorio 47
GB - Regno Unito 47
IN - India 33
FI - Finlandia 26
BE - Belgio 23
NL - Olanda 19
AT - Austria 16
MX - Messico 13
CA - Canada 9
TR - Turchia 8
JP - Giappone 6
AU - Australia 5
IR - Iran 5
MA - Marocco 5
DK - Danimarca 4
PL - Polonia 4
ES - Italia 3
KR - Corea 3
PH - Filippine 3
AR - Argentina 2
CH - Svizzera 2
CO - Colombia 2
PA - Panama 2
TH - Thailandia 2
VE - Venezuela 2
ZA - Sudafrica 2
BD - Bangladesh 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
IL - Israele 1
LT - Lituania 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
PE - Perù 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 4.408
Città #
Chandler 328
Des Moines 230
Fairfield 226
Singapore 205
Hong Kong 194
Jacksonville 176
Dublin 154
Ashburn 148
Seattle 112
Boardman 109
Wilmington 106
Houston 96
Woodbridge 95
Cambridge 82
Lawrence 58
Princeton 58
Moscow 51
San Mateo 48
Abidjan 47
Rome 45
New York 44
Ann Arbor 43
Turin 34
Helsinki 26
The Dalles 25
London 23
Pune 21
San Diego 21
Brussels 17
Milan 15
Ancona 14
Washington 14
Mexico City 12
Centro 11
Beijing 10
Dallas 10
Falls Church 10
Shanghai 10
Vienna 10
Frankfurt am Main 9
Kilburn 9
São Paulo 9
Los Angeles 8
Guangzhou 7
Jinan 7
Messina 7
Mohali 7
Norwalk 7
Wuhan 6
Boydton 5
Civitanova Marche 5
Hangzhou 5
Izmir 5
Nuremberg 5
Shenzhen 5
Tolentino 5
Toronto 5
Council Bluffs 4
Hrebenne 4
Redwood City 4
Wandsworth 4
Bilbao 3
Brisbane 3
Cremona 3
Fayetteville 3
Guarulhos 3
Hounslow 3
Monte Porzio Catone 3
Piracicaba 3
Quanzhou 3
Santa Clara 3
Tokyo 3
Yiwu 3
Adelaide 2
Agugliano 2
Amsterdam 2
Ashville 2
Bangkok 2
Belo Horizonte 2
Birmingham 2
Carisio 2
Caserta 2
Chions 2
Farmington Hills 2
Frankfurt Am Main 2
Hamburg 2
Heze 2
Islington 2
Istanbul 2
Jinhua 2
Legaspi Port 2
Marche 2
Mjölby 2
Modena 2
Montesilvano Marina 2
Osimo 2
Ottawa 2
Panama City 2
Perugia 2
Redmond 2
Totale 3.160
Nome #
Maternal hair testing to disclose self-misreporting in drinking and smoking behavior during pregnancy 209
A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid 205
THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis" 100
Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid 100
Toxicology and analysis of psychoactive tryptamines 96
Monitoring Prenatal Exposure to Buprenorphine and Methadone 91
UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis 90
Acute Intoxications and Fatalities Associated with Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review 89
European drug users at risk from illicit fentanyls mix 86
Herbal preparations of medical cannabis: A vademecum for prescribing doctors 85
Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 83
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids 82
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 79
Cannabidiol adverse effects and toxicity 78
Commentary - Heroin purity and adulteration: An updated snapshot from the Italian Early Warning System 77
Measurement uncertainty in forensic toxicology 76
Determination of the synthetic cannabinoids JWH-122, JWH-210, UR-144 in oral fluid of consumers by GC-MS and quantification of parent compounds and metabolites by UHPLC-MS/MS 75
Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 75
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair 74
Correspondence 73
Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry 73
Dilute and shoot ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) analysis of psychoactive drugs in oral fluid 72
Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study 69
Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use 68
Pharmacology and legal status of cannabidiol 66
Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis 65
Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease 64
Synthetic cathinones related fatalities: an update 64
Analytical advances in clinical and forensic toxicology. Second part 63
Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update 63
Clarifying methodological issues in cannabinoids determination in bronchoalveolar lavages 59
Metabolic pathways and potencies of new fentanyl analogs 59
Comment on "direct Monitoring of Exogenous γ-Hydroxybutyric Acid in Body Fluids by NMR Spectroscopy": Several Issues to Consider When Quantifying γ-Hydroxybutyric Acid in Biological Matrixes 59
Advances and future developments in forensic toxicology: From standard practices to new psychoactive substances 58
Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: A pilot study 58
A fatal chemsex case involving γ-butyrolactone and 4-methylethcathinone 58
The importance of biomarkers of fetal exposure to alcohol and psychotropic drugs in early diagnosis: A case report 56
Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices 53
Ultra-high-performance liquid chromatography tandem mass spectrometry assay for determination of endogenous ghb and ghb-glucuronide in nails 53
UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations 53
Medicinal cannabis and synthetic cannabinoid use 53
GHB concentration in breast milk of narcoleptic women treated with sodium oxybate. How important it is to be careful when interpreting values 50
Pharmacotoxicology of non-fentanyl derived new synthetic opioids 50
Stability of cannabinoids in cannabis FM1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry 49
Segmental hair testing of triazolam to unmask a suspected case of idiopathic recurrent Stupor 48
Global prevalence of fetal alcohol spectrum disorder in Italy 48
Editorial: The challenge posed by new synthetic opioids: Pharmacology and toxicology 48
The National Early Warning System, a web-based platform to prevent the spread of New Psychoactive Substances 46
Analytical procedures and blood threshold values to ascertain driving in a stae of psycho-physical impairment from drugs abuse|Procedure analitiche e valori decisionali ematici per accertare la guida in stato di alterazione psicofisica da sostanze d'abuso 45
Cannabis: Neurological correlates in abuse and medical use 45
Editorial: Analytical Advances in Clinical and Forensic Toxicology 45
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 44
GHB side effects: The need to clearly document drug dose and administration history 44
New psychoactive substances: A matter of time 44
The issue of psychotropic drug monitoring in sexual assault victims 43
Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans 38
Herbal highs: Review on Psychoactive Effects and Neuropharmacology 38
Nails in Forensic Toxicology: an Update 37
The complex and constantly evolving public health threat of new psychoactive substances in Italy: Addressing the main functions of a national observatory of drugs 37
Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs 34
UHPLC-MS-MS Determination of THC, CBD and Their Metabolites in Whole Blood of Light Cannabis Smokers 32
The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances 32
QuEChERS Extraction and Simultaneous Quantification in GC-MS/MS of Hexahydrocannabinol Epimers and Their Metabolites in Whole Blood, Urine, and Oral Fluid 30
Effects of subtoxic 3-methylmethcathinone concentrations on neuronal cell electrical properties 28
Analysis of perfluoroalkyl substances ({PFAS}) in conventional and unconventional matrices: Clinical outcomes 27
Molecular Insights on New Psychoactive Substances (NPSs) 27
Pharmacological effects of methylone and MDMA in humans 27
Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH 22
Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches? 22
“Tranq-dope”: The first fatal intoxication due to xylazine-adulterated heroin in Italy 21
The new synthetic benzimidazole opioid etonitazepipne: an emerging fatal harm and a challenge for laboratory medicine 21
Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for quantitative determination of methylone and some of its metabolites in oral fluid 21
Recent challenges and trends in forensic analysis: Δ9-THC isomers pharmacology, toxicology and analysis 20
Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans 19
A “special dose” of ethics in forensic toxicology 19
Erratum to Reduced prevalence of fetal exposure to alcohol in Italy: a nationwide survey American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 6, June 2023, 100944 18
Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users 17
Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy 17
Disposition of phytocannabinoids, their acidic precursors and their metabolites in biological matrices of healthy individuals treated with vaporized medical cannabis 17
Molecular Insights of New Psychoactive Substances (NPS) 2.0 16
GHB-facilitated sexual assaults: How to proper assess a single GHB exposure in hair 16
Editorial: Drug-drug interactions in pharmacology 15
Target Analysis of NPS in Oral Fluid 10
Totale 4.536
Categoria #
all - tutte 30.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.205


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202074 0 0 0 0 0 0 0 0 0 0 20 54
2020/2021845 53 48 78 3 49 63 114 115 72 77 76 97
2021/2022436 39 58 18 7 3 41 4 29 46 34 55 102
2022/20231.093 88 124 79 75 45 308 8 59 211 3 75 18
2023/2024594 79 12 81 54 84 115 26 21 8 17 14 83
2024/20251.323 118 119 89 71 86 124 144 93 352 115 12 0
Totale 4.536